AU2011352333B2 - Improved methods for determining cell viability using molecular nucleic acid-based techniques - Google Patents

Improved methods for determining cell viability using molecular nucleic acid-based techniques Download PDF

Info

Publication number
AU2011352333B2
AU2011352333B2 AU2011352333A AU2011352333A AU2011352333B2 AU 2011352333 B2 AU2011352333 B2 AU 2011352333B2 AU 2011352333 A AU2011352333 A AU 2011352333A AU 2011352333 A AU2011352333 A AU 2011352333A AU 2011352333 B2 AU2011352333 B2 AU 2011352333B2
Authority
AU
Australia
Prior art keywords
pcr
cells
dna
microbe
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011352333A
Other languages
English (en)
Other versions
AU2011352333A1 (en
Inventor
Shawn Mark O'hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeus Scientific Inc
Original Assignee
Zeus Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeus Scientific Inc filed Critical Zeus Scientific Inc
Publication of AU2011352333A1 publication Critical patent/AU2011352333A1/en
Application granted granted Critical
Publication of AU2011352333B2 publication Critical patent/AU2011352333B2/en
Priority to AU2017201390A priority Critical patent/AU2017201390A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2011352333A 2010-12-31 2011-12-27 Improved methods for determining cell viability using molecular nucleic acid-based techniques Ceased AU2011352333B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017201390A AU2017201390A1 (en) 2010-12-31 2017-02-28 Improved methods for determining cell viability using molecular nucleic acid-based techniques

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061428892P 2010-12-31 2010-12-31
US61/428,892 2010-12-31
PCT/US2011/067329 WO2012092238A1 (en) 2010-12-31 2011-12-27 Improved methods for determining cell viability using molecular nucleic acid-based techniques

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017201390A Division AU2017201390A1 (en) 2010-12-31 2017-02-28 Improved methods for determining cell viability using molecular nucleic acid-based techniques

Publications (2)

Publication Number Publication Date
AU2011352333A1 AU2011352333A1 (en) 2013-08-15
AU2011352333B2 true AU2011352333B2 (en) 2016-12-08

Family

ID=46383494

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2011352333A Ceased AU2011352333B2 (en) 2010-12-31 2011-12-27 Improved methods for determining cell viability using molecular nucleic acid-based techniques
AU2017201390A Abandoned AU2017201390A1 (en) 2010-12-31 2017-02-28 Improved methods for determining cell viability using molecular nucleic acid-based techniques

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2017201390A Abandoned AU2017201390A1 (en) 2010-12-31 2017-02-28 Improved methods for determining cell viability using molecular nucleic acid-based techniques

Country Status (8)

Country Link
US (1) US20140186828A1 (enExample)
EP (1) EP2659001A4 (enExample)
JP (2) JP2014502510A (enExample)
CN (1) CN103476945A (enExample)
AU (2) AU2011352333B2 (enExample)
CA (1) CA2862523A1 (enExample)
NZ (1) NZ613671A (enExample)
WO (1) WO2012092238A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN09421A (enExample) * 2012-04-12 2015-07-17 Zeus Scientific Inc
US10495555B2 (en) * 2013-10-08 2019-12-03 David Putnam Filter-cartridge based fluid-sample preparation and assay system
US10112194B2 (en) 2014-04-14 2018-10-30 Q-Linea Ab Detection of microscopic objects
GB201617713D0 (en) * 2016-10-19 2016-11-30 Q-Linea Ab Method for recovering microbial cells
EP3673086B1 (en) * 2017-08-24 2025-04-09 Roche Diagnostics GmbH Electrochemical detection of bacterial and/or fungal infections
US11319582B2 (en) * 2019-07-19 2022-05-03 Pathogendx, Inc. Methods for microbial DNA analysis
DE102020103971B4 (de) * 2020-02-14 2022-02-24 Testo bioAnalytics GmbH Verfahren zum Nachweis von lebenden Mikroorganismen und ein fluidisches Kanalsystem

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210881B1 (en) * 1996-12-30 2001-04-03 Becton, Dickinson And Company Method for reducing inhibitors of nucleic acid hybridization
WO2002052034A1 (fr) * 2000-12-26 2002-07-04 Joji Oshima Methodes de bioscopie et d'amplification d'acides nucleiques
WO2007100762A2 (en) * 2006-02-28 2007-09-07 Montana State University Use of phenanthridium derivatives for distinguishing between intact and membrane-compromised cells using molecular nucleic acid-based techniques
WO2009082747A1 (en) * 2007-12-24 2009-07-02 Zeus Scientific, Inc. Methods and compositions including diagnostic kits for the detection of staphylococcus aureus

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002354838B2 (en) * 2001-07-19 2007-11-29 Infectio Diagnostic (I.D.I.) Inc. Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection
JP4414332B2 (ja) * 2002-07-12 2010-02-10 アクソン・ニューロサイエンス・フォルシュングス−ウント・エントヴィックルングス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング アルツハイマーｔａｕタンパク質を発現するトランスジェニック動物
CA2448098A1 (en) * 2002-11-26 2004-05-26 Paul A. Horgen Ultrasensitive detection of pathogenic microbes
US20050160528A1 (en) * 2003-07-28 2005-07-28 Clark Steven F. Bed frame with integral air purifying device
US7759348B2 (en) * 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
FR2885140B1 (fr) * 2005-04-29 2010-12-31 Millipore Corp Procede de detection et de caracterisation de microorgarnismes sur une membrane.
JP2008125457A (ja) * 2006-11-22 2008-06-05 Asahi Breweries Ltd 微生物の検出方法
JP5245379B2 (ja) * 2007-12-04 2013-07-24 株式会社日立プラントテクノロジー 捕集デバイス、及びそれを用いる分析システム
GB0723797D0 (en) * 2007-12-05 2008-01-16 Immunosolv Ltd Method
JP2009159868A (ja) * 2007-12-28 2009-07-23 Institute Of Physical & Chemical Research 造血幹細胞の維持・増幅方法
DK2262520T3 (en) * 2008-02-26 2017-08-07 Univ Cornell COMPOSITIONS FOR PREVENTION AND TREATMENT OF Kidney Injury
WO2009125804A1 (ja) * 2008-04-09 2009-10-15 武田薬品工業株式会社 スクリーニング方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210881B1 (en) * 1996-12-30 2001-04-03 Becton, Dickinson And Company Method for reducing inhibitors of nucleic acid hybridization
WO2002052034A1 (fr) * 2000-12-26 2002-07-04 Joji Oshima Methodes de bioscopie et d'amplification d'acides nucleiques
WO2007100762A2 (en) * 2006-02-28 2007-09-07 Montana State University Use of phenanthridium derivatives for distinguishing between intact and membrane-compromised cells using molecular nucleic acid-based techniques
WO2009082747A1 (en) * 2007-12-24 2009-07-02 Zeus Scientific, Inc. Methods and compositions including diagnostic kits for the detection of staphylococcus aureus

Also Published As

Publication number Publication date
NZ613671A (en) 2017-01-27
AU2017201390A1 (en) 2017-03-23
AU2011352333A1 (en) 2013-08-15
EP2659001A4 (en) 2014-07-02
JP2016192967A (ja) 2016-11-17
JP2014502510A (ja) 2014-02-03
US20140186828A1 (en) 2014-07-03
WO2012092238A1 (en) 2012-07-05
CN103476945A (zh) 2013-12-25
EP2659001A1 (en) 2013-11-06
CA2862523A1 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
AU2015273443B2 (en) Method for detecting and characterising a microorganism
US8877436B2 (en) Fast results hybrid capture assay on an automated platform
EP2558600B1 (en) Methods for measuring enzyme activity useful in determining cell viability in non-purified samples
AU2017201390A1 (en) Improved methods for determining cell viability using molecular nucleic acid-based techniques
JP2014502510A5 (enExample)
US20210371940A1 (en) Process for identifying and quantifying nucleic acid sequences from live microorganisms
US20110200984A1 (en) Using nucleic acids for clinical microbiology testing
US20160083776A1 (en) Methods for Measuring Polymerase Activity Useful for Sensitive, Quantitative Measurements of Any Polymerase Extension Activity and for Determining the Presence of Viable Cells

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired